Literature DB >> 32959767

Methanol Fixation, but not Giemsa Staining, Inactivates Ebola and Lassa Viruses in Peripheral Blood Smears Made on Plastic Microscope Slides.

Ryan F Relich1,2, Heinz Feldmann3, Elaine Haddock3.   

Abstract

Diseases caused by many highly pathogenic viruses, including Ebola virus (EBOV) and Lassa virus (LASV), present with nonspecific signs and symptoms that overlap with common tropical diseases such as malaria. Initial diagnostic tests performed on patients under investigation for viral hemorrhagic fevers routinely include analysis of peripheral blood smears to detect and quantify Plasmodium species. In light of recent and ongoing Ebola virus disease and Lassa fever epidemics, clinical laboratories around the world require protocols for dealing with highly infectious specimens from patients with suspected or confirmed high-consequence diseases. Few validated protocols for safe analysis of peripheral blood smears are available, revealing a need for further research. In this study, we evaluated the performance of two plastic microscope slide types that offer safe alternatives to glass slides, determined the temporal parameters required to inactivate EBOV and LASV in thin blood smears by methanol fixation, and assessed the virucidal activity of Giemsa stain. Both types of plastic microscope slides performed optimally; there were no significant differences in blood cell morphology or tinctorial properties nor were differences noted in Plasmodium ovale morphology or staining, when compared with glass slides. For both EBOV and LASV, viable viruses were not detected in thin blood smears following fixation in absolute methanol for at least 2 minutes. By contrast, viable EBOV and LASV were recovered from all Giemsa-stained thick blood smears.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32959767      PMCID: PMC7646817          DOI: 10.4269/ajtmh.19-0840

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Performance of BinaxNOW for diagnosis of malaria in a U.S. hospital.

Authors:  Michael A Dimaio; Irma T Pereira; Tracy I George; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

2.  The 2014 Dallas, Texas, Ebola Incident: Global Implications to All-Hazards Preparedness and Health Care Worker Protection.

Authors:  Christopher Eddy; Eriko Sase
Journal:  J Environ Health       Date:  2015-09       Impact factor: 1.179

3.  First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014.

Authors:  M A Lopaz; C Amela; M Ordobas; M F Dominguez-Berjon; C Alvarez; M Martinez; M J Sierra; F Simon; J M Jansa; D Plachouras; J Astray
Journal:  Euro Surveill       Date:  2015-01-08

4.  Case Report: Imported Case of Lassa Fever - New Jersey, May 2015.

Authors:  Prathit A Kulkarni; Debra Chew; Manal Youssef-Bessler; Hanaa A Hamdi; Lindsay A Montoya; Kimberly B Cervantes; Nicole L Mazur; Diana Lucas; Julia W Wells; David Cennimo; Anne Sutherland; Linda M Di Domenico; Lincoln P Miller; Frantz Pierre-Louis; Gregory Rokosz; Atif Nazir; Marie A de Perio; Luis Lowe; Craig Manning; Kenneth R Mead; Bryan E Christensen; César G Albariño; Ute Ströher; Maleeka Glover; Edward I Lifshitz; Christina G Tan; Pierre E Rollin; Shereen Semple
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

5.  Inactivating Zaire Ebolavirus in Whole-Blood Thin Smears Used for Malaria Diagnosis.

Authors:  Todd A. Cutts; Bradley W. M. Cook; Guillaume Poliquin; James E. Strong; Steven S Theriault
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

6.  Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell cultures.

Authors:  Manfred Weidmann; Amadou A Sall; Jean-Claude Manuguerra; Lamine Koivogui; Aime Adjami; Faye Fatou Traoré; Kjell-Olof Hedlund; Gunnel Lindegren; Ali Mirazimi
Journal:  Virol J       Date:  2011-02-24       Impact factor: 4.099

7.  Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.

Authors:  Andrea Marzi; Friederike Feldmann; Patrick W Hanley; Dana P Scott; Stephan Günther; Heinz Feldmann
Journal:  Emerg Infect Dis       Date:  2015-10       Impact factor: 6.883

8.  Ebola virus disease cluster in the United States--Dallas County, Texas, 2014.

Authors:  Michelle S Chevalier; Wendy Chung; Jessica Smith; Lauren M Weil; Sonya M Hughes; Sibeso N Joyner; Emily Hall; Divya Srinath; Julia Ritch; Prea Thathiah; Heidi Threadgill; Diana Cervantes; David L Lakey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-21       Impact factor: 17.586

Review 9.  High-Containment Pathogen Preparation in the Intensive Care Unit.

Authors:  Brian T Garibaldi; Daniel S Chertow
Journal:  Infect Dis Clin North Am       Date:  2017-09       Impact factor: 5.982

10.  Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods.

Authors:  Anna Grahn; Andreas Bråve; Thomas Tolfvenstam; Marie Studahl
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.